Handbook: The Duty for "Sponsor Oversight" in Clinical Research. A Practical Guide 1st Edition
Par :Formats :
Disponible dans votre compte client Decitre ou Furet du Nord dès validation de votre commande. Le format ePub est :
- Compatible avec une lecture sur My Vivlio (smartphone, tablette, ordinateur)
- Compatible avec une lecture sur liseuses Vivlio
- Pour les liseuses autres que Vivlio, vous devez utiliser le logiciel Adobe Digital Edition. Non compatible avec la lecture sur les liseuses Kindle, Remarkable et Sony
, qui est-ce ?Notre partenaire de plateforme de lecture numérique où vous retrouverez l'ensemble de vos ebooks gratuitement
Pour en savoir plus sur nos ebooks, consultez notre aide en ligne ici
C'est si simple ! Lisez votre ebook avec l'app Vivlio sur votre tablette, mobile ou ordinateur :
- Nombre de pages71
- FormatePub
- ISBN978-3-7562-0062-7
- EAN9783756200627
- Date de parution26/07/2022
- Protection num.Digital Watermarking
- Taille1 Mo
- Infos supplémentairesepub
- ÉditeurBooks on Demand
Résumé
The evidence that the sponsor of a clinical trial fulfills the obligation to perform oversight of, e.g. a CRO that carries out outsourced study activities on behalf of the sponsor is not new. Nevertheless, the addendum to the ICH-GCP has explicitly included this as a sponsor responsibility under point 5.2.2. It applies to all sponsors of a clinical trial, independent of the kind of the clinical trial, whether commercial or academic study, if the study activities are outsourced to a CRO.
The goal is to ensure the patient safety and data integrity. The review of the sponsor's oversight is also subject to e.g. an inspection by an authority. The first edition of this manual is based on a master's thesis within the framework of the university master's program "Clinical Research". The concept developed is certainly not completely new but is based, inter alia. to already discussed measures or publications, as example, by the English authority MHRA.
It is intended to serve as an example to illustrate how the sponsor's duty of supervision can be implemented simply and efficiently in rather small, medium-sized companies. Of course, every company has to decide for itself how to implement it.
The goal is to ensure the patient safety and data integrity. The review of the sponsor's oversight is also subject to e.g. an inspection by an authority. The first edition of this manual is based on a master's thesis within the framework of the university master's program "Clinical Research". The concept developed is certainly not completely new but is based, inter alia. to already discussed measures or publications, as example, by the English authority MHRA.
It is intended to serve as an example to illustrate how the sponsor's duty of supervision can be implemented simply and efficiently in rather small, medium-sized companies. Of course, every company has to decide for itself how to implement it.
The evidence that the sponsor of a clinical trial fulfills the obligation to perform oversight of, e.g. a CRO that carries out outsourced study activities on behalf of the sponsor is not new. Nevertheless, the addendum to the ICH-GCP has explicitly included this as a sponsor responsibility under point 5.2.2. It applies to all sponsors of a clinical trial, independent of the kind of the clinical trial, whether commercial or academic study, if the study activities are outsourced to a CRO.
The goal is to ensure the patient safety and data integrity. The review of the sponsor's oversight is also subject to e.g. an inspection by an authority. The first edition of this manual is based on a master's thesis within the framework of the university master's program "Clinical Research". The concept developed is certainly not completely new but is based, inter alia. to already discussed measures or publications, as example, by the English authority MHRA.
It is intended to serve as an example to illustrate how the sponsor's duty of supervision can be implemented simply and efficiently in rather small, medium-sized companies. Of course, every company has to decide for itself how to implement it.
The goal is to ensure the patient safety and data integrity. The review of the sponsor's oversight is also subject to e.g. an inspection by an authority. The first edition of this manual is based on a master's thesis within the framework of the university master's program "Clinical Research". The concept developed is certainly not completely new but is based, inter alia. to already discussed measures or publications, as example, by the English authority MHRA.
It is intended to serve as an example to illustrate how the sponsor's duty of supervision can be implemented simply and efficiently in rather small, medium-sized companies. Of course, every company has to decide for itself how to implement it.
